Printer Friendly
The Free Library
14,537,290 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cholestech Corporation Announces Continuing Education Program for Retail Pharmacy.


Business Editors and Health/Medical Writers

HAYWARD, Calif.--(BUSINESS WIRE)--August 1, 2000

Cholestech Corporation (Nasdaq:CTEC CTEC Course and Teacher Evaluation Council (Northwestern University, Office of the Register)
CTEC Certified Technical Education Center
CTEC Certified Technical Education Center (Microsoft) 
) announced today that it has completed the development of the Cholestech Lipid lipid

Any of a diverse class of organic compounds, found in all living things, that are greasy and insoluble in water. One of the three large classes of substances in foods and living cells, lipids contain more than twice as much energy (calories) per unit of weight as the
 ACTION(TM) Program, a continuing education continuing education: see adult education.
continuing education
 or adult education

Any form of learning provided for adults. In the U.S. the University of Wisconsin was the first academic institution to offer such programs (1904).
 program designed to help pharmacists This is a list of notable pharmacists.
  • Dora Akunyili, Director General of National Agency for Food and Drug Administration and Control of Nigeria
  • Charles Alderton (1857 - 1941), American inventor the soft drink Dr Pepper
  • George F.
 establish a successful business in offering lipid management services in retail pharmacy settings.

Supported through an unrestricted educational grant-in-aid from Merck and Company, Inc. (NYSE NYSE

See: New York Stock Exchange
:MRK MRK Merck & Company (stock symbol)
MRK Mayer-Rokitansky-Kuster (anomaly)
MRK Manual Remote Keying
), the program was developed by MedOutcomes of Virginia, a consulting firm Noun 1. consulting firm - a firm of experts providing professional advice to an organization for a fee
consulting company

business firm, firm, house - the members of a business organization that owns or operates one or more establishments; "he worked for a
 specializing in designing and delivering continuing education programs for pharmacists. The in-person educational program will be delivered for the first time at the California Pharmacy Association meeting in Pasadena, on September 24, 2000. The Cholestech Lipid ACTION Program Guidebook was released last year.

"We found the Cholestech Lipid ACTION Program Guidebook to be comprehensive and easy to follow," said William Wimmer of Goodrich Pharmacy in Elk River Elk River

1. A river rising in the Cumberland Mountains of south-central Tennessee and meandering about 322 km (200 mi) generally west-southwest into northern Alabama.

2. A river, about 277 km (172 mi) long, of central West Virginia.
, Minn. "It provides all of the necessary tools a pharmacy needs to establish a successful lipid management service including site preparation, use of the Cholestech L-D-X(R) System, collaboration with physicians, and billing. It is easy to follow and will be instrumental in helping pharmacies achieve their financial objectives of offering cardiovascular care services."

"The release of the Cholestech Lipid ACTION Program demonstrates our commitment to provide tools necessary to ensure that our pharmacy customers can achieve desired business results with the use of the Cholestech LoDoX System. It further reinforces Cholestech's vision of preventive care Preventive care is a set of measures taken in advance of symptoms to prevent illness or injury. This type of care is best exemplified by routine physical examinations and immunizations. The emphasis is on preventing illnesses before they occur. See also
  • Public health
 testing and ongoing management of chronic disease in the pharmacy and other health care delivery points which offer easy access to patients," said Robert J. Dominici, executive vice president and chief operating officer Chief Operating Officer (COO)

The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president.
 of Diagnostic Products. "We're pleased to work with Med Outcomes and Merck to further establish a leading position in the advancement of pharmaceutical care to promote improved patient outcomes."

About Cholestech

Cholestech is committed to helping people successfully improve their health. Working together, the Cholestech business units of Diagnostic Products, WellCheck(TM), and WellCheck.com, can provide simple, accessible, and reliable personal health information to health care practitioners and consumers in over 35 countries around the world. By offering efficient and economic diagnostic screening for cholesterol, blood sugar, and liver function, Cholestech hopes to help more people understand whether or not they face potentially serious health risks. Therapeutic monitoring options using the Cholestech L-D-X(R) System can help patients monitor their progress as they work with their health care provider to reduce their risk of cardiovascular and other diseases. Working together with health care providers, our goal is to ultimately enable people to lead longer, healthier, and more active lives.

For more information about Cholestech and its products visit us on the web at www.cholestech.com Our cholesterol management site is available to the general public at www.wellcheck.com.

This release contains forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
 as defined in the Private Securities Litigations Reform Act of 1995, including statements regarding: the successful development of lipid management services in retail pharmacy settings; the potential financial advantages to pharmacies in offering cardiovascular care services; and Cholestech's ability to establish a leading position in the advancement of pharmaceutical care. Actual results may differ materially from those in the forward-looking statements due to risks and uncertainties, including: changing relationships with customers, suppliers, and strategic partners; potential contractual, intellectual property, or employment issues; delays; the loss of a significant customer; the availability and pricing of competing products and services and the resulting effects on sales and pricing of our products and services; and other factors.

Note to Editors: Cholestech L-D-X(R), WellCheck(TM), WellCheck.com, and Cholestech Lipid ACTION(TM) are registered or pending trademarks of Cholestech Corporation. All other trademarks mentioned in this document are the property of their respective owners.
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Aug 1, 2000
Words:620
Previous Article:Agilera Aligns With ITAA to Educate IT Market on Competitive Advantages of ASPs; Agilera Selected for ITAA ``Membership Spotlight'' Based on Its...
Next Article:ADVISORY/The Job Fair, Inc. Presents Two Atlanta, Georgia Area `Career Fest 2000 Events' Tuesday, August 8th and August 9th.
Topics:



Related Articles
Cholestech L.D.X. System receives waiver from key federal regulation; quick, accurate blood analyzer now more accessible for physicians, pharmacists,...
Cholestech Corporation and AmeriSource Health Corporation Announce Pharmacy Distribution Agreement; Proprietary Cholestech L.D.X System will enable...
Cholestech Reports Third Quarter of Fiscal 1999 Results.
Cholestech L.D.X System Chosen for Parke-Davis' 1999 Disease Management Initiative.
Cholestech L.D.X System Chosen for Parke-Davis' 1999 Disease Management Initiative at CVS Drug Stores.
Project ImPACT:Hyperlipidemia Final Results Announced With the Cholestech L.D.X System.
Cholestech Corp. Launches WellCheck.com.
Cholestech Announces the Launch of the WellCheck Personal Health Management Program.
Michael D. Casey of Matrix Pharmaceutical Joins Cholestech Board of Directors.
Special delivery: most studies show mail-order pharmacies save money for insurers and consumers, but retail stores are demanding to be an option,...

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles